Burning Rock Biotech (BNR) Debt to Equity (2019 - 2025)

Burning Rock Biotech (BNR) recorded quarterly Debt to Equity of $0.0 in Q4 2025, up 8.96% quarter-over-quarter from $0.0 in Q3 2025.

Burning Rock Biotech (BNR) Debt to Equity (2019 - 2025) Analysis & Trends

Burning Rock Biotech's Debt to Equity history runs 5 years deep, the most recent figure standing at $0.0 for Q4 2025.

In Q4 2025, Debt to Equity changed N/A year-over-year to $0.0; the TTM figure through Dec 2025 stood at $0.0 (changed N/A YoY), while the FY2025 annual figure was $0.0, changed N/A from the prior year.
Debt to Equity was $0.0 for Q4 2025 at Burning Rock Biotech, up from $0.0 in the prior quarter.
In the past five years, Debt to Equity ranged from a high of $0.99 in Q2 2022 to a low of $0.0 in Q3 2025.
Historically, Debt to Equity has averaged $0.22 across 3 years, with a median of $0.01 in 2021.
The sharpest annual moves came in 2021 and 2022: Debt to Equity declined 19.56% in 2021, then surged 7050.13% in 2022.
A 3-year view of Debt to Equity shows it stood at $0.49 in 2021, then surged by 103.16% to $0.99 in 2022, then plunged by 99.64% to $0.0 in 2025.
The last three Debt to Equity figures came in at $0.0 (Q4 2025), $0.0 (Q3 2025), and $0.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	0.32
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	0.83
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	0.35
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	0.53
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	-1.50
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	0.01
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	2.49
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	0.56
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	-53.21
10	Burning Rock Biotech	20.64 Mn	-47.19 Mn	14.10 Mn	0.00

Download Data